drugset / Trial / NCT00636636
Safety and Efficacy of Gabapentin in Postherpetic Neuralgia
RandomizedParallel-groupDouble-blindTreatment
Summary
Gabapentin and pregabalin are treatments for some types of neuropathic pain, including postherpetic neuralgia (PHN). However, these treatments usually need to be taken 3 times a day for effective pain control. The purpose of this study is to determine whether a new gabapentin tablet, which only needs to be taken once a day, is safe and effective for the treatment of postherpetic neuralgia.
Timeline
- Start
- 2008-03
- Primary completion
- 2009-08
- Completion
- 2009-09
Outcome
Met primary endpoint
registry analysis (superiority or other test); G-ER vs Placebo; p = 0.0125; Least squares mean difference -0.49 (95% CI -0.88 to -0.11); ANCOVA NCT00636636 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Unknown | 1800 mg | — |